January 26, 2024
Conducting mentored clinical and translation research by CTSC Trainees and Scholars.
Featured presenter:
Jaclyn Rosenzweig, MD
CTSC KL2 Scholar and Master’s Degree candidate
Preclinical Evaluation of the Selective LSDI Inhibitor IMG-7289 in Pediatric Relapsed and Refractory Acute Myelogenous Leukemia (AML)